Significant Progress in Lupus Diagnosis

Systemic lupus erythematosus (SLE) is an inflammatory autoimmune disease in which the immune system attacks own tissues and organs. Serious SLE can lead to life-threatening conditions. The accurate diagnosis of SLE is challenging because of the variety of symptoms, often non-specific and common symptoms of other diseases. SCIENION’s customer ImmunArray provides a new In Vitro Diagnostic Test to tackle this problem.

ImmunArray has developed the SLE-key® test to rule-out a diagnosis of Systemic Lupus Erythematous (SLE) with unparalleled levels of accuracy. The simple blood test profiles a patient’s immune system, gaining insight into the state of the disease by analyzing a broad array of antibodies. ImmunArray’s proprietary antigen microarrays are produced with SCIENION’s sciFLEXARRAYER

ImmunArray is a molecular device company dedicated to the development of novel blood based in vitro diagnostic tests to support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases. The test measures the repertoire of circulating antibodies to an array of antigens which are printed on ImmunArray’s proprietary iCHIP®
 

 

 

 

 

 

 

Since 2011, ImmunArray has been using the sciFLEXARRAYER technology to print their multiplex chips, with progressively reinforcing number and sizes of the sciFLEXARRAYER dispensers. SLE-key® is the first product of ImmunArray in the market.


"We print from 200 from 500 different antigens on the chip, depending on the disease that we are monitoring. We have been working together with SCIENION for several years, we started with one of their smaller instruments and now we are happy to own two of their largest instruments."

Donna Edmonds, Chairman & CEO of ImmunArray Diagnostics